Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Behavioral Studies and Practices (BSPJ)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03685292
Recruitment Status : Completed
First Posted : September 26, 2018
Last Update Posted : September 26, 2018
Sponsor:
Collaborator:
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Brian Bolden, Foundation of iAesthetics and Neurobiology

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The focus of this study is to evaluate whether a new fraud material will be suitable for a technological device and or software. ***For consultation purposes only.***

Condition or disease Intervention/treatment
Behavioral Behavioral: Behavioral Advisory System Drug: Behavioral Treatment Device: Behavioral Division

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 37 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: "Fraud Case Study" - The Tone At The Top and What Constitutes Criminal Behavior.
Actual Study Start Date : April 1, 2018
Actual Primary Completion Date : April 30, 2018
Actual Study Completion Date : May 12, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Health Fraud

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
Group A
Subject(s): A Subgroup
 Behavioral: Behavioral Advisory System
Support and training to help increase throughput while promoting upstanding stature and reproducibility in behavioral testing using cutting edge methodologies.
Other Name: Triple Helix Methodology System

Drug: Behavioral Treatment
This study addressed the efficacy of cognitive-behavioral therapy (CBT) treatment.

Device: Behavioral Division
This study is relative to minimal contact control (MCC).
Group B
Subject(s): B Subgroup
 Behavioral: Behavioral Advisory System
Support and training to help increase throughput while promoting upstanding stature and reproducibility in behavioral testing using cutting edge methodologies.
Other Name: Triple Helix Methodology System

Drug: Behavioral Treatment
This study addressed the efficacy of cognitive-behavioral therapy (CBT) treatment.

Device: Behavioral Division
This study is relative to minimal contact control (MCC).
Group C
Subject(s): C Sub Group
 Behavioral: Behavioral Advisory System
Support and training to help increase throughput while promoting upstanding stature and reproducibility in behavioral testing using cutting edge methodologies.
Other Name: Triple Helix Methodology System

Drug: Behavioral Treatment
This study addressed the efficacy of cognitive-behavioral therapy (CBT) treatment.

Device: Behavioral Division
This study is relative to minimal contact control (MCC).


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Questionnaire/Screening [ Time Frame: 30 days ]
    The tool, intended to assess college students' by classmates, includes one portion that is an online self-administered questionnaire. Guidance counselors can use the questionnaire to identify college students students who have been targeted for "Fraud."


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   19 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
African-American Cased-Based
Criteria

Inclusion Criteria:

  • College Student

Exclusion Criteria:

  • Age Over 40
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03685292


Locations
Layout table for location information
United States, Louisiana
The Southern University
Baton Rouge, Louisiana, United States, 70807
Sponsors and Collaborators
Brian Bolden
National Institutes of Health (NIH)
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Additional Information:

Layout table for additonal information
Responsible Party: Brian Bolden, Student, Foundation of iAesthetics and Neurobiology
ClinicalTrials.gov Identifier: NCT03685292    
Other Study ID Numbers: Behavioral Studies Journal
0037 ( Registry Identifier: Southern University and A&M Colleges )
First Posted: September 26, 2018    Key Record Dates
Last Update Posted: September 26, 2018
Last Verified: July 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: Behavioral Analysis- Punishment is the least effective method of changing behavior Causes only a "temporary suppression of the behavior" Behavior returned when punishment discontinued

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: Yes
Studies a U.S. FDA-regulated Device Product: Yes
Product Manufactured in and Exported from the U.S.: No